Century Therapeutics, Inc.IPSCNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank83
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
11.36%
↑ 1070% vs avg
Percentile
P83
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
0.97%
Historical baseline
PeriodValue
Q4 202511.36%
Q3 202515.05%
Q2 2025-146.22%
Q1 2025298.95%
Q4 2024-7.17%
Q3 2024-0.10%
Q2 2024-11.01%
Q1 202428.46%
Q4 2023-22.84%
Q3 2023-1.57%
Q2 2023-9.34%
Q1 20233.68%
Q4 2022-4.94%
Q3 2022-1.23%
Q2 202216.25%
Q1 2022-33.83%
Q4 2021-8.31%
Q3 2021-12.19%
Q2 2021-27.46%
Q1 2021-18.38%
Q4 2020-16.20%
Q3 2020-21.65%
Q2 2020-8.02%
Q1 20200.00%